Alimera Sells Some Assets to B&L

Alimera Sciences Inc., an Atlanta-based ophthalmic pharmaceutical company, has sold its OTC allergy franchise (including antihistamine Alaway) to Bausch & Lomb. No financial terms were disclosed. Alimera has recently closed its Series B round with a total of $31.8 million, from firms like BA Venture Partners, Domain Associates, Intersouth Partners, Polaris Venture Partners and Venrock Associates.